共 50 条
- [46] Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review FRONTIERS IN ONCOLOGY, 2025, 14
- [50] Complete Response of Primary Refractory ALK-Positive Large B-Cell Lymphoma Treated With Single-Agent Nivolumab CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (03): : E113 - E117